LITTLE FALLS, N.J., June 8, 2011 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMN) reported an 18% increase in net income to $5,048,000, or $0.29 per diluted share, on a 24% increase in sales to a record $82,619,000 for the third quarter ended April 30, 2011. This compares with net income of $4,274,000, or $0.25 per diluted share, on sales of $66,559,000 for the third quarter ended April 30, 2010. For the nine months ended April 30, 2011, the Company reported net income of $15,743,000, or $0.91 per diluted share, on a 15% increase in sales to $235,633,000. This compares with net income of $15,318,000, or $0.90 per diluted share, on sales of $204,141,000 for the nine months ended April 30, 2010.
Andrew Krakauer, Cantel's President and CEO stated, "We are pleased to have delivered record sales and another quarter of improved earnings. It is positive to see sales increases in our three major business segments -- Endoscope Reprocessing, Water Purification and Filtration, and Healthcare Disposables -- all with significant core growth. These solid results confirm the continued success of our three-prong approach to growth which includes investing in new product development, sales and marketing programs and acquisitions."
Krakauer added, "As in the first half of this fiscal year, our Endoscope Reprocessing business had remarkable performance in the quarter as sales increased by 67%, driven by shipments of our two newest reprocessors, the Advantage® Plus and the DSD Edge™, as well as disinfectants and sterilants, parts and service. This accomplishment is a result of successful new product development, the effectiveness and quality of our sales and marketing teams, as well as improvements in hospital spending worldwide. Acquisition related integration and startup costs negatively affected operating income in the quarter in both our Water Purification
|SOURCE Cantel Medical Corp.|
Copyright©2010 PR Newswire.
All rights reserved